For patients with early-stage lung cancer, the journey from diagnosis to treatment often involves multiple procedures spread across several weeks or even months. During that time, patients may undergo separate biopsies to confirm a diagnosis, additional tests to determine whether the cancer has spread, procedures to help surgeons locate difficult-to-find tumors and, finally, surgery to remove the cancer. Research suggests that these delays can affect outcomes, with longer intervals between diagnosis and treatment associated with higher rates of recurrence and lower survival.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Augmented Reality Thoracic Surgery and the Patient Experience | 0 | 9.4 | 01-09-2026 |
| 2 | Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer | 0 | 6.4 | 01-09-2026 |
| 3 | Perioperative Toripalimab in Stage III Non–Small Cell Lung Cancer | 0 | 14.35 | 01-09-2026 |
| 4 | From professor to patient: One man's journey on the frontier of lung cancer treatment | 0 | 7.28 | 27-09-2026 |
| 5 | From professor to patient: One man's journey on the frontier of lung cancer treatment | 0 | 7.28 | 27-09-2026 |
| 6 | Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice | 0 | 7.8 | 25-09-2026 |
| 7 | Lumpectomy Margins and Local Recurrence in DCIS | 0 | 8.55 | 01-09-2026 |
| 8 | ‘Persistent gaps’ in lung cancer screening communication | 0 | 8.49 | 22-09-2026 |
| 9 | Patients with lung malignancy have more airway microplastics | 0 | 8.14 | 25-09-2026 |
| 10 | Recalibrating “Unresectable” in Pancreatic Cancer | 0 | 12.62 | 01-09-2026 |